ZIOPHARM ONCOLOGY

ziopharm-oncology-logo

Ziopharm Oncology is a biotechnology company employing a novel gene expression and control technology to deliver DNA for the treatment of cancer. ZIOPHARM's technology platform employs Intrexon Corporation's RheoSwitch Therapeutic Systemยฎ to turn on and off and precisely modulate gene expression at the cancer site in order to improve the therapeutic index. This technology is currently being evaluated in Phase 2 clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma. Multiple new INDs for new targets using similar technology are expected in 2014 and 2015. ZIOPHARM is also developing novel small molecules as potential cancer therapeutics.

#SimilarOrganizations #People #Financial #Event #Website #More

ZIOPHARM ONCOLOGY

Social Links:

Industry:
Biotechnology Genetics Pharmaceutical Therapeutics

Founded:
2005-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.ziopharm.com

Total Employee:
11+

Status:
Active

Contact:
617-259-1970

Email Addresses:
[email protected]

Total Funding:
277.69 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

kairos-biomedical-logo

Kairos BioMedical

Kairos BioMedical is a biomedical company that discovers, develops, and commercializes immuno preventative and therapeutic products.

nutcracker-therapeutics-logo

Nutcracker Therapeutics

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.


Current Advisors List

jonathan-lewis_image

Jonathan Lewis Chairman @ Ziopharm oncology
Board_member

scott-braunstein_image

Scott Braunstein Board Member @ Ziopharm oncology
Board_member
2018-01-01

Current Employees Featured

satyavrat-shukla_image

Satyavrat Shukla
Satyavrat Shukla Chief Financial Officer & EVP @ Ziopharm oncology
Chief Financial Officer & EVP
2019-01-01

kevin-boyle_image

Kevin Boyle
Kevin Boyle Chief Executive Officer @ Ziopharm oncology
Chief Executive Officer
2021-08-01

robert-hadfield_image

Robert Hadfield
Robert Hadfield EVP, General Counsel, Secretary & Chief Compliance Officer @ Ziopharm oncology
EVP, General Counsel, Secretary & Chief Compliance Officer
2018-04-01

haroon-hashmi_image

Haroon Hashmi
Haroon Hashmi Vice President Regulatory Affairs @ Ziopharm oncology
Vice President Regulatory Affairs
2017-04-01

Founder


jonathan-lewis_image

Jonathan Lewis

Stock Details


Company's stock symbol is NASDAQ:ZIOP

Investors List

henderson-global-investors_image

Henderson Global Investors

Henderson Global Investors investment in Post-IPO Equity - Ziopharm oncology

essex-woodlands-health-ventures_image

Essex Woodlands Healthcare Partners

Essex Woodlands Healthcare Partners investment in Post-IPO Equity - Ziopharm oncology

proquest-investments_image

ProQuest Investments

ProQuest Investments investment in Post-IPO Equity - Ziopharm oncology

pinto-technology-ventures_image

Pinto Technology Ventures

Pinto Technology Ventures investment in Post-IPO Equity - Ziopharm oncology

lbi-group_image

LBI Group

LBI Group investment in Post-IPO Equity - Ziopharm oncology

proquest-investments_image

ProQuest Investments

ProQuest Investments investment in Post-IPO Equity - Ziopharm oncology

pangaea-asset-management_image

Pangaea Asset Management

Pangaea Asset Management investment in Post-IPO Equity - Ziopharm oncology

paramount-biocapital-asset-management_image

Paramount BioCapital Asset Management

Paramount BioCapital Asset Management investment in Post-IPO Equity - Ziopharm oncology

lbi-group_image

LBI Group

LBI Group investment in Post-IPO Equity - Ziopharm oncology

cycad-group_image

Cycad Group

Cycad Group investment in Post-IPO Equity - Ziopharm oncology

Official Site Inspections

http://www.ziopharm.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ziopharm oncology" on Search Engine